Skip to main content
Premium Trial:

Request an Annual Quote

Asuragen Armored RNA Quant Zika Virus Control

Asuragen has launched its custom Armored RNA Quant Zika Virus target, which can be used to develop molecular assays. The company's Armored RNA Quant technology is the gold standard for reliable and traceable standards to develop molecular assays for virus quantitation, the company said. Developed in collaboration with Jan Felix Drexler, professor at the University of Bonn Medical Center and the German Center for Infection Research, the control is a multi-gene target designed using seven genes from the Zika Brazilian reference sequence KU321639.

The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.